Cargando…
Rhino-orbital-cerebral mucormycosis in COVID-19 patients – Taming the black evil with pharmacological weapons
Autores principales: | Kaur, Kirandeep, Gurnani, Bharat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641742/ https://www.ncbi.nlm.nih.gov/pubmed/34854414 http://dx.doi.org/10.4103/ijp.ijp_392_21 |
Ejemplares similares
-
COVID-19 and Rhino-Cerebral Mucormycosis: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022) -
Rhino-Orbital-Cerebral Mucormycosis and Orbital Exenteration
por: Fahrenkopf, Matthew P., et al.
Publicado: (2016) -
Modified drug regimen for ophthalmic anesthesia during COVID-19 pandemic: Revisiting pharmacological concepts
por: Gurnani, Bharat, et al.
Publicado: (2021) -
Role of medial orbital wall decompression in COVID-19-associated rhino-orbital mucormycosis management
por: Murthy, Ramesh, et al.
Publicado: (2021) -
The “black evil” affecting patients with diabetes: a case of rhino orbito cerebral mucormycosis causing Garcin syndrome
por: Narayanan, Santhosh, et al.
Publicado: (2017)